These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11560770)

  • 1. Retrovirus-mediated transfer and expression of beta-hexosaminidase alpha-chain cDNA in human fibroblasts from G(M2)-gangliosidosis B1 variant.
    Teixeira CA; Sena-Esteves M; Lopes L; Sá Miranda MC; Ribeiro MG
    Hum Gene Ther; 2001 Sep; 12(14):1771-83. PubMed ID: 11560770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.
    Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K
    Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
    Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
    Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase.
    Tse R; Vavougios G; Hou Y; Mahuran DJ
    Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C
    Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic correction in microglia derived from Sandhoff disease model mice.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K
    J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of acid beta-galactosidase deficiency in GM1 gangliosidosis human fibroblasts by retrovirus vector-mediated gene transfer: higher efficiency of release and cross-correction by the murine enzyme.
    Sena-Esteves M; Camp SM; Alroy J; Breakefield XO; Kaye EM
    Hum Gene Ther; 2000 Mar; 11(5):715-27. PubMed ID: 10757351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical consequences of mutations causing the GM2 gangliosidoses.
    Mahuran DJ
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):105-38. PubMed ID: 10571007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoters for the human beta-hexosaminidase genes, HEXA and HEXB.
    Norflus F; Yamanaka S; Proia RL
    DNA Cell Biol; 1996 Feb; 15(2):89-97. PubMed ID: 8634145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis.
    Ornaghi F; Sala D; Tedeschi F; Maffia MC; Bazzucchi M; Morena F; Valsecchi M; Aureli M; Martino S; Gritti A
    Neurobiol Dis; 2020 Feb; 134():104667. PubMed ID: 31682993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration.
    Kyrkanides S; Miller JH; Brouxhon SM; Olschowka JA; Federoff HJ
    Brain Res Mol Brain Res; 2005 Feb; 133(2):286-98. PubMed ID: 15710246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrovirus-mediated enzymatic correction of Tay-Sachs defect in transduced and non-transduced cells.
    Guidotti J; Akli S; Castelnau-Ptakhine L; Kahn A; Poenaru L
    Hum Mol Genet; 1998 May; 7(5):831-8. PubMed ID: 9536087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of functional domains within the alpha and beta subunits of beta-hexosaminidase A through the expression of alpha-beta fusion proteins.
    Tse R; Wu YJ; Vavougios G; Hou Y; Hinek A; Mahuran DJ
    Biochemistry; 1996 Aug; 35(33):10894-903. PubMed ID: 8718882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic determination of plasma and leukocyte beta-hexosaminidase isoenzymes in homozygote and heterozygote carriers for the GM2 gangliosidosis B1 variant.
    Casal JA; Pérez LF; Tutor JC
    Am J Clin Pathol; 2003 May; 119(5):684-8. PubMed ID: 12760286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM2 gangliosidosis associated with a HEXA missense mutation in Japanese Chin dogs: a potential model for Tay Sachs disease.
    Sanders DN; Zeng R; Wenger DA; Johnson GS; Johnson GC; Decker JE; Katz ML; Platt SR; O'Brien DP
    Mol Genet Metab; 2013 Jan; 108(1):70-5. PubMed ID: 23266199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of metabolic cross-correction in Tay-Sachs cells: implications for gene therapy.
    Martino S; Emiliani C; Tancini B; Severini GM; Chigorno V; Bordignon C; Sonnino S; Orlacchio A
    J Biol Chem; 2002 Jun; 277(23):20177-84. PubMed ID: 11923278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis.
    Sonderfeld S; Brendler S; Sandhoff K; Galjaard H; Hoogeveen AT
    Hum Genet; 1985; 71(3):196-200. PubMed ID: 2933318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors.
    Leal AF; Cifuentes J; Quezada V; Benincore-Flórez E; Cruz JC; Reyes LH; Espejo-Mojica AJ; Alméciga-Díaz CJ
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
    Suzuki K; Vanier MT
    Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.